Gelmon K - Search Results

1

The effect of zidovudine on platelet count in HIV-infected individuals.

Montaner JS, Le T, Fanning M, Gelmon K, Tsoukas C, Falutz J, O'Shaughnessy M, Wainberg MA, Ruedy J. Montaner JS, et al. Among authors: gelmon k. J Acquir Immune Defic Syndr (1988). 1990;3(6):565-70. J Acquir Immune Defic Syndr (1988). 1990. PMID: 2187071 Clinical Trial.

2

Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy. Canadian Zidovudine Multi-Centre Study Group.

Rooke R, Tremblay M, Soudeyns H, DeStephano L, Yao XJ, Fanning M, Montaner JS, O'Shaughnessy M, Gelmon K, Tsoukas C, et al. Rooke R, et al. Among authors: gelmon k. AIDS. 1989 Jul;3(7):411-5. doi: 10.1097/00002030-198907000-00001. AIDS. 1989. PMID: 2504243

3

Nature, time course and dose dependence of zidovudine-related side effects: results from the Multicenter Canadian Azidothymidine Trial.

Gelmon K, Montaner JS, Fanning M, Smith JR, Falutz J, Tsoukas C, Gill J, Wells G, O'Shaughnessy M, Wainberg M, et al. Gelmon K, et al. AIDS. 1989 Sep;3(9):555-61. doi: 10.1097/00002030-198909000-00001. AIDS. 1989. PMID: 2528969 Clinical Trial.

4

Cessation of zidovudine therapy may lead to increased replication of HIV-1.

Wainberg MA, Falutz J, Fanning M, Gill J, Gelmon K, Montaner JS, O'Shaughnessy M, Tsoukas C, Ruedy J. Wainberg MA, et al. Among authors: gelmon k. JAMA. 1989 Feb 10;261(6):865-6. JAMA. 1989. PMID: 2913381 No abstract available.

5

HIV-1 and the aetiology of AIDS.

Schechter MT, Craib KJ, Gelmon KA, Montaner JS, Le TN, O'Shaughnessy MV. Schechter MT, et al. Among authors: gelmon ka. Lancet. 1993 Mar 13;341(8846):658-9. doi: 10.1016/0140-6736(93)90421-c. Lancet. 1993. PMID: 8095571

6

Aetiology of AIDS.

Schechter MT, Craib KJ, Montaner JS, Lee TN, O'Shaughnessy MV, Gelmon KA. Schechter MT, et al. Among authors: gelmon ka. Lancet. 1993 May 8;341(8854):1222-3. doi: 10.1016/0140-6736(93)91060-y. Lancet. 1993. PMID: 8098118 No abstract available.

7

Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study.

Shepherd FA, Beaulieu R, Gelmon K, Thuot CA, Sawka C, Read S, Singer J. Shepherd FA, et al. Among authors: gelmon k. J Clin Oncol. 1998 May;16(5):1736-42. doi: 10.1200/JCO.1998.16.5.1736. J Clin Oncol. 1998. PMID: 9586886 Clinical Trial.

8

Efficacy of weekly cisplatin-based chemotherapy in recurrent and metastatic head and neck cancer.

Osoba D, Band PR, Goldie JH, Connors JM, Gelmon K, Knowling MA, Fetherstonhaugh EM. Osoba D, et al. Among authors: gelmon k. Ann Oncol. 1992 Aug;3 Suppl 3:57-62. doi: 10.1093/annonc/3.suppl_3.s57. Ann Oncol. 1992. PMID: 1390318

9

Interim results of a phase I/II study of biweekly paclitaxel and cisplatin in patients with metastatic breast cancer.

Tolcher AW, Gelmon KA. Tolcher AW, et al. Among authors: gelmon ka. Semin Oncol. 1995 Aug;22(4 Suppl 8):28-32. Semin Oncol. 1995. PMID: 7638639 Clinical Trial.

10

Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer.

Gelmon KA, O'Reilly SE, Tolcher AW, Campbell C, Bryce C, Ragaz J, Coppin C, Plenderleith IH, Ayers D, McDermott B, Nakashima L, Healey D, Onetto N. Gelmon KA, et al. J Clin Oncol. 1996 Apr;14(4):1185-91. doi: 10.1200/JCO.1996.14.4.1185. J Clin Oncol. 1996. PMID: 8648373 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

380 results

Search Page

Filters